OrthoPediatrics Corp. KIDS 深 沪
等待开盘 04-01 09:30:00 美东时间
15.87
+0.670
+4.41%
华盛通- 最 高16.457
- 今 开15.43
- 成交量 25.55万股
- 最 低 15.085
- 昨 收 15.20
- 总市值 4.01亿
- 52周最高 23.70
- 市盈率 静 --
- 换手率 1.01%
- 52周最低 14.91
- 委 比 34.38%
- 总股本 2527.88万
- 历史最高 73.91
- 量 比 1.43
- 振 幅 9.03%
- 历史最低 14.00
- 每 手 1
- 风险率 2.19%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多OrthoPediatrics to Participate in the 25th Annual Needham Virtual Healthcare Conference
OrthoPediatrics Corp. announced that its President & CEO, Dave Bailey, and COO & CFO, Fred Hite, will participate in a fireside chat at the 25th Annual Needham Virtual Healthcare Conference on April 14, 2026, at 9:30 am ET. The event will be webcast live and available for replay on the company’s investor relations website. Founded in 2006, OrthoPediatrics specializes in pediatric orthopedics, offering over 85 products across trauma, scoliosis, an...
03-31 20:05
美股大行评级 | 花旗：维持康菲石油"买入"评级！目标价从125美元升至135美元
今日重点评级关注：HC Wainwright & Co.：维持Helus Pharma"买入"评级，目标价从55美元升至95美元；HC Wainwright & Co.：维持Compass Pathways"买入"评级，目标价从40美元升至70美元
03-03 20:22
美股大行评级 | 下调居多！多邻国、Elastic、Flutter、欧特克、Zscaler等遭多家机构下调目标价
今日重点评级关注：巴克莱：维持C4 Therapeutics"超配"评级，目标价从5美元升至7美元；富国银行：维持Agilon Health"超配"评级，目标价从1美元升至1.5美元
03-02 14:08
BTIG Maintains Buy on OrthoPediatrics, Raises Price Target to $24
BTIG analyst Ryan Zimmerman maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises the price target from $23 to $24.
02-27 18:36
OrthoPediatrics Announces Expanded Enabling Technology Market Opportunity
OrthoPediatrics partner iotaMotion receives FDA clearance for expanded use of its iotaSOFT® cochlear implant insertion system in patients four years and older. The system, designed to enhance cochlear implant surgery by controlling electrode insertion speed and consistency, is now available for school-aged children. Cincinnati Children’s Hospital becomes the first dedicated pediatric center to adopt the technology, which is already used by over 3...
02-03 12:05
美股大行评级 | 瑞穗上调希捷科技、西部数据、CoreWeave目标价；Trade Desk、W.R. Berkley遭多家大行下调目标价
今日重点评级关注：瑞穗：维持Syndax制药"跑赢大市"评级，目标价从410美元升至600美元；HC Wainwright & Co.：维持60 Degrees Pharmaceuticals, Inc."买入"评级，目标价从6美元升至24美元
01-28 10:59
TD Cowen Initiates Coverage On OrthoPediatrics with Buy Rating, Announces Price Target of $23
TD Cowen analyst Mathew Blackman initiates coverage on OrthoPediatrics (NASDAQ:KIDS) with a Buy rating and announces Price Target of $23.
01-27 21:48
OrthoPediatrics sees FY25 revenue of $236.1M
OrthoPediatrics (KIDS) on Monday said posted record preliminary unaudited full year 2025 net revenue of $236.1 million, representing continued growth compared to $204.7 million in 2024 of 15%. Prelimi...
01-12 20:50
OrthoPediatrics Raises FY2025 Sales Guidance from $233.500M-$234.500M to $236.100M vs $234.002M Est
OrthoPediatrics (NASDAQ:KIDS) raises FY2025 sales outlook from $233.500 million-$234.500 million to $236.100 million vs $234.002 million estimate.
01-12 20:08
快讯 | OrthoPediatrics Corp. 创下2025年全年未经审计初步收入记录，并发布2026年财务指引
OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Ye...
01-12 20:05
